To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RAB11FIP3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
335 supporting clones for gene RAB11FIP3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AB014565 brain .a 1 to 4081 1 to 4080 exact tiling clone, available from KIAA,   4080/4080
(100 %)
2 diff
(100.0 %id)
AF395731   .a 1 to 4081 1 to 4080 exact     4080/4080
(100 %)
2 diff
(100.0 %id)
CN415377 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 25 to 321 1 to 297       297/297
(100 %)
1 diff
(99.7 %id)
BC051360 Ovary, teratocarcinoma .a 50 to 4300 1 to 4250 exact available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 4250/4250
(100 %)
2 diff
(100.0 %id)
NM_014700.3   .a 50 to 4300 1 to 4251 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 4251/4251
(100 %)
0 diff
(100 %id)
AL079700 testis .a 51 to 456 1 to 405       405/405
(100 %)
1 diff
(99.8 %id)
BU848904 ovary, teratocarcinoma, cell line .a 51 to 593 1 to 542       542/1017
(53 %)
3 diff
(99.8 %id)
BU856535 ovary, teratocarcinoma, cell line .a 51 to 605 1 to 552       552/986
(55 %)
8 diff
(99.2 %id)
CN415378 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 65 to 289 1 to 225       225/225
(100 %)
0 diff
(100 %id)
BQ052479 blood, natural killer cells, cell line .a 626 to 1109 11 to 497       487/1148
(42 %)
25 diff
(97.9 %id)
DA215195 brain .a 826 to 1311 2 to 488   capped   487/487
(100 %)
1 diff
(99.8 %id)
CO246802 Chondrosarcoma Lung Metastasis cell lines, lung .a 834 to 1353 8 to 526       519/706
(73 %)
22 diff
(96.9 %id)
CO403072 Chondrosarcoma Lung Metastasis cell lines, lung .a 834 to 1450 36 to 646       611/751
(81 %)
14 diff
(98.2 %id)
CN335897 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 880 to 1403 1 to 524       524/524
(100 %)
0 diff
(100 %id)
CD358443 testis .a 906 to 1298 75 to 467       393/1040
(37 %)
13 diff
(98.8 %id)
DA864196 placenta .a 1028 to 1584 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BQ883723 brain, neuroblastoma, cell line .a 1126 to 1972 15 to 861       847/917
(92 %)
9 diff
(99.1 %id)
BQ212638 melanotic melanoma, skin .a 1226 to 2111 1 to 891       891/924
(96 %)
20 diff
(97.9 %id)
DR978660 brain .a 1228 to 1321 93 to 1       93/99
(93 %)
3 diff
(97.0 %id)
EH344588   .a 1333 to 1396 1 to 64       64/64
(100 %)
0 diff
(100 %id)
BQ332502 lung_tumor .a 1600 to 2084 493 to 3       491/493
(99 %)
26 diff
(94.8 %id)
BQ344423 nervous_tumor .a 1603 to 1875 274 to 1       274/274
(100 %)
7 diff
(97.5 %id)
TI_1948226618   .a 1688 to 2658 1104 to 136       969/1280
(75 %)
23 diff
(98.3 %id)
BU181369 epithelioid carcinoma, Pancreas .a 1753 to 2499 1 to 755       755/883
(85 %)
16 diff
(98.2 %id)
AI358176 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1780 to 2173 394 to 1       394/395
(99 %)
6 diff
(98.5 %id)
DA623660 Kidney .a 1821 to 2354 2 to 535   capped   534/534
(100 %)
2 diff
(99.7 %id)
CR995444 T-Lymphocytes .a 1829 to 2557 1 to 730       730/730
(100 %)
1 diff
(99.9 %id)
AA413401   .a 1896 to 2139 245 to 1     Submitted on the opposite strand 245/245
(100 %)
6 diff
(97.6 %id)
BQ685474 ductal carcinoma, cell line, Pancreas .a 1948 to 2808 1 to 869       869/872
(99 %)
10 diff
(98.9 %id)
DA275451 corpus callosum .a 1964 to 2515 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
AY130007 medulloblastoma .a 1981 to 4304 1 to 2350   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2350/2350
(100 %)
10 diff
(99.6 %id)
AL043391 testis .a 2007 to 2238 1 to 235       235/235
(100 %)
5 diff
(97.9 %id)
TI_1948226617   .a 2027 to 2658 756 to 127       630/1234
(51 %)
16 diff
(98.8 %id)
DA299524 hippocampus .a 2033 to 2609 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
BU173173 eye, retinoblastoma .a 2049 to 2395 1 to 350       350/818
(42 %)
5 diff
(99.4 %id)
DA022844   .a 2053 to 2618 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
AA774937 schizophrenic brain S-11 frontal lobe .a 2060 to 2191 1 to 132     Submitted on the opposite strand 132/132
(100 %)
1 diff
(99.3 %id)
BM908747 astrocytoma grade IV, cell line, brain .a 2109 to 2425 143 to 459       317/1097
(28 %)
8 diff
(99.3 %id)
BM913664 astrocytoma grade IV, cell line, brain .a 2109 to 2425 143 to 459       317/1119
(28 %)
8 diff
(99.3 %id)
BM914094 astrocytoma grade IV, cell line, brain .a 2109 to 2425 144 to 461       318/1146
(27 %)
9 diff
(99.3 %id)
BG326306 Kidney, renal cell adenocarcinoma .a 2115 to 2789 1 to 709       617/977
(63 %)
47 diff
(95.2 %id)
CV799311 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2135 to 2765 1 to 628       628/813
(77 %)
27 diff
(96.7 %id)
CR996492 T-Lymphocytes .a 2210 to 2888 1 to 682       682/682
(100 %)
3 diff
(99.6 %id)
BQ057256 lymph, lymphoma, cell line .a 2216 to 2715 80 to 583       504/1259
(40 %)
24 diff
(98.1 %id)
BQ069630 brain, neuroblastoma, cell line .a 2227 to 3181 1 to 964       964/1064
(90 %)
31 diff
(97.1 %id)
BU527703 epidermoid carcinoma, cell line, lung .a 2241 to 3034 3 to 818       816/1018
(80 %)
33 diff
(96.8 %id)
CN335898 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2249 to 2607 1 to 359       359/359
(100 %)
0 diff
(100 %id)
CA488259   .a 2252 to 2771 86 to 616       531/1279
(41 %)
18 diff
(98.6 %id)
BQ355112 head_neck .a 2268 to 2649 1 to 388       388/396
(97 %)
60 diff
(84.9 %id)
DB001407 breast, tumor tissue .a 2280 to 2806 2 to 528   capped   527/527
(100 %)
6 diff
(98.9 %id)
BE140677 head_neck .a 2286 to 2470 201 to 21     Submitted on the opposite strand 181/201
(90 %)
5 diff
(97.6 %id)
BM564169 blood, natural killer cells, cell line .a 2364 to 3340 1 to 985       985/1148
(85 %)
33 diff
(97.2 %id)
BM917037 blood, natural killer cells, cell line .a 2365 to 3224 1 to 873       873/1172
(74 %)
40 diff
(96.6 %id)
AL079628 testis .a 2380 to 2852 1 to 473       473/474
(99 %)
4 diff
(99.2 %id)
BM550875 duodenal adenocarcinoma, cell line, small intestine .a 2381 to 3240 1 to 865       865/1052
(82 %)
23 diff
(97.9 %id)
BF830193 head_normal .a 2402 to 2778 402 to 30     Submitted on the opposite strand 373/411
(90 %)
12 diff
(97.1 %id)
BM543501 brain, hippocampus .a 2414 to 3368 28 to 999       972/1005
(96 %)
36 diff
(96.5 %id)
TI_154185729   .a 2519 to 3204 109 to 779       671/913
(73 %)
18 diff
(98.1 %id)
TI_154186101   .a 2519 to 3477 119 to 1053       935/997
(93 %)
34 diff
(96.6 %id)
Z36827 Pancreas .a 2571 to 2858 1 to 290       290/320
(90 %)
17 diff
(94.7 %id)
F11160 brain, total brain .a 2593 to 2861 1 to 269       269/269
(100 %)
0 diff
(100 %id)
DR759725 embryonic stem .a 2614 to 3248 1 to 635       635/635
(100 %)
0 diff
(100 %id)
CR622821 fetal brain .a 2624 to 4303 1 to 1680       1680/1680
(100 %)
0 diff
(100 %id)
BX461168 brain, fetal brain .a 2624 to 3619 1 to 988       988/988
(100 %)
13 diff
(98.7 %id)
F08006 brain, total brain .a 2626 to 2864 1 to 239       239/239
(100 %)
1 diff
(99.6 %id)
Z44562 brain, total brain .a 2626 to 2927 1 to 302       302/302
(100 %)
1 diff
(99.7 %id)
F07385 brain, total brain .a 2626 to 2923 1 to 299       299/299
(100 %)
1 diff
(99.7 %id)
H09992 whole brain .a 2627 to 3042 1 to 425     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 425/425
(100 %)
16 diff
(96.3 %id)
T77413 whole brain .a 2649 to 3026 1 to 371       371/371
(100 %)
11 diff
(97.1 %id)
TI_57178492   .a 2660 to 3406 21 to 777       757/777
(97 %)
6 diff
(99.3 %id)
BI769140 pooled lung and spleen .a 2670 to 3406 1 to 747       747/747
(100 %)
30 diff
(96.0 %id)
BQ890109 Spleen .a 2671 to 3162 1 to 498       498/1294
(38 %)
23 diff
(98.3 %id)
DB010676 colon, tumor tissue .a 2679 to 3218 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
BM705075 eye, RPE and Choroid .a 2683 to 2849 1 to 167       167/167
(100 %)
0 diff
(100 %id)
BM709104 eye, RPE and Choroid .a 2683 to 2840 1 to 158       158/158
(100 %)
0 diff
(100 %id)
CR982621 T-Lymphocytes .a 2692 to 3323 1 to 632       632/633
(99 %)
1 diff
(99.9 %id)
CR985358 T-Lymphocytes .a 2692 to 3218 1 to 527       527/529
(99 %)
1 diff
(99.9 %id)
CN344857 embryonic stem cells, DMSO-treated H9 cellline .a 2815 to 3414 8 to 607       600/607
(98 %)
6 diff
(99.1 %id)
BF737827 bladder_tumor .a 2833 to 3144 343 to 32     Submitted on the opposite strand 312/360
(86 %)
0 diff
(100 %id)
AW842718 colon_normal .a 2834 to 3026 201 to 8       194/201
(96 %)
0 diff
(100 %id)
BQ054166 blood, natural killer cells, cell line .a 2837 to 3703 1 to 877       877/1079
(81 %)
20 diff
(98.2 %id)
BG334263 melanotic melanoma, skin .a 2866 to 3549 2 to 675   AAA   674/927
(72 %)
18 diff
(98.1 %id)
BQ674858 epidermoid carcinoma, cell line, salivary gland .a 2872 to 3723 1 to 857       857/916
(93 %)
21 diff
(97.8 %id)
BQ889536 epidermoid carcinoma, cell line, salivary gland .a 2872 to 3735 1 to 876       876/884
(99 %)
30 diff
(96.7 %id)
BU163708 epidermoid carcinoma, cell line, salivary gland .a 2872 to 3394 1 to 533       533/1020
(52 %)
27 diff
(97.4 %id)
BQ672689 epidermoid carcinoma, cell line, salivary gland .a 2872 to 3417 1 to 547       547/975
(56 %)
10 diff
(99.0 %id)
BQ670335 epidermoid carcinoma, cell line, salivary gland .a 2872 to 3636 1 to 773       773/1026
(75 %)
21 diff
(98.0 %id)
BQ673082 epidermoid carcinoma, cell line, salivary gland .a 2872 to 3584 1 to 729       729/1011
(72 %)
43 diff
(95.8 %id)
CD625945   .a 2884 to 3585 708 to 14       695/708
(98 %)
0 diff
(100 %id)
CD625946   .a 2887 to 3543 1 to 655       655/655
(100 %)
6 diff
(99.1 %id)
BM554174 amelanotic melanoma, cell line, skin .a 2901 to 3839 26 to 962       937/1142
(82 %)
8 diff
(99.3 %id)
BM911375 amelanotic melanoma, cell line, skin .a 2902 to 3342 1 to 442       442/1163
(38 %)
11 diff
(99.1 %id)
BM912127 amelanotic melanoma, cell line, skin .a 2902 to 3567 1 to 672       672/1145
(58 %)
21 diff
(98.2 %id)
BM912573 amelanotic melanoma, cell line, skin .a 2902 to 3412 1 to 514       514/1196
(42 %)
11 diff
(99.1 %id)
BY796590 eye .a 2916 to 3475 1 to 560       560/560
(100 %)
2 diff
(99.7 %id)
BM711142 eye, fetal eyes .a 2916 to 3380 1 to 465       465/465
(100 %)
0 diff
(100 %id)
TI_154186114   .a 2927 to 3579 122 to 773       652/920
(70 %)
10 diff
(99.0 %id)
AA323921 brain, cerebellum .a 2934 to 3277 1 to 344       344/344
(100 %)
1 diff
(99.8 %id)
AW955175   .a 2935 to 3504 1 to 566       566/566
(100 %)
28 diff
(95.1 %id)
AJ712967 bone marrow .a 2942 to 3361 17 to 436       420/436
(96 %)
11 diff
(97.5 %id)
BM663881 eye, RPE and Choroid .a 2970 to 3619 669 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 651/651
(100 %)
4 diff
(99.4 %id)
DR979556 placenta .a 2971 to 3094 1 to 123     Submitted on the opposite strand 123/131
(93 %)
6 diff
(95.5 %id)
CX754765 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2995 to 3631 1 to 633     Submitted on the opposite strand 633/795
(79 %)
7 diff
(99.2 %id)
EB385479 eye, optic nerve .a 2997 to 3767 1 to 771       771/771
(100 %)
1 diff
(99.9 %id)
BG329195 eye, retinoblastoma .a 3047 to 3702 1 to 673       673/1111
(60 %)
35 diff
(96.9 %id)
BE251617 eye, retinoblastoma .a 3068 to 3688 1 to 621       621/621
(100 %)
0 diff
(100 %id)
CN344855 embryonic stem cells, DMSO-treated H9 cellline .a 3110 to 3786 1 to 677       677/677
(100 %)
2 diff
(99.8 %id)
AA055405 colon, tumor .a 3119 to 3531 1 to 415       415/416
(99 %)
9 diff
(97.9 %id)
CN344854 embryonic stem cells, DMSO-treated H9 cellline .a 3140 to 3486 1 to 347       347/347
(100 %)
0 diff
(100 %id)
AA425081 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3147 to 3502 1 to 355       355/355
(100 %)
6 diff
(98.4 %id)
R24299 whole brain .a 3161 to 3460 1 to 301       301/301
(100 %)
6 diff
(98.1 %id)
CB216536 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 3167 to 3797 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
AW067867 Bone, Hip .a 3181 to 3624 1 to 448       448/448
(100 %)
5 diff
(98.9 %id)
BG007818 placenta_normal .a 3191 to 3461 297 to 23       275/297
(92 %)
0 diff
(100 %id)
AI824935 pooled germ cell tumors .a 3216 to 3616 410 to 10       401/410
(97 %)
0 diff
(100 %id)
AW262648 brain, three pooled meningiomas .a 3223 to 3616 394 to 1       394/394
(100 %)
14 diff
(96.5 %id)
BM720419 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3237 to 3605 1 to 369     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 369/369
(100 %)
1 diff
(99.8 %id)
BU147493 dorsal root ganglia .a 3267 to 3864 1 to 598   AAA   598/879
(68 %)
1 diff
(99.9 %id)
BU146541 epidermoid carcinoma, cell line, salivary gland .a 3268 to 3994 1 to 756       756/906
(83 %)
18 diff
(98.1 %id)
AI492392 Kidney .a 3299 to 3616 318 to 1       318/318
(100 %)
1 diff
(99.7 %id)
AI245375 Kidney .a 3307 to 3624 318 to 1       318/327
(97 %)
1 diff
(99.7 %id)
CT003091 T-Lymphocytes .a 3384 to 3532 1 to 149       149/198
(75 %)
1 diff
(99.5 %id)
BX452089 brain, fetal brain .a 3398 to 4305 1 to 927       927/927
(100 %)
25 diff
(97.4 %id)
BX431627.
matches multiple genes
brain, fetal brain .a 3400 to 3806 1 to 406     also hits gene flystoyby 406/467
(86 %)
19 diff
(96.0 %id)
CV328652 nervous_tumor .a 3408 to 3541 133 to 1     Submitted on the opposite strand 133/236
(56 %)
5 diff
(97.9 %id)
AV694604 hepatocellular carcinoma .a 3436 to 3847 1 to 406       406/406
(100 %)
4 diff
(99.1 %id)
CA395186 eye, RPE/choroid .a 3445 to 3703 1 to 259       259/259
(100 %)
0 diff
(100 %id)
TI_154117773   .a 3480 to 4104 757 to 107   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 651/921
(70 %)
19 diff
(98.0 %id)
AI765466 2 pooled tumors (clear cell type), Kidney .a 3563 to 4300 730 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 720/835
(86 %)
34 diff
(96.0 %id)
BF951232 nervous_normal .a 3573 to 3805 233 to 2       232/236
(98 %)
0 diff
(100 %id)
AW611819 Kidney .a 3576 to 4100 525 to 1       525/525
(100 %)
1 diff
(99.9 %id)
TI_151717491   .a 3583 to 4304 849 to 124   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 726/733
(99 %)
11 diff
(98.5 %id)
TI_154020413   .a 3584 to 4300 800 to 85   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 716/716
(100 %)
3 diff
(99.6 %id)
CA423764 cell lines, Chondrosarcoma .a 3584 to 4102 539 to 21   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 519/521
(99 %)
0 diff
(100 %id)
TI_227715179   .a 3590 to 4304 796 to 87   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 710/946
(75 %)
9 diff
(99.1 %id)
CN344856 embryonic stem cells, cell lines H1, H7, andH9 .a 3605 to 4301 1 to 716       716/716
(100 %)
11 diff
(98.5 %id)
BU622678 cell lines, Chondrosarcoma .a 3626 to 4304 693 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 675/675
(100 %)
5 diff
(99.3 %id)
BU615830 Bone, Subchondral Bone .a 3627 to 4304 687 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 669/669
(100 %)
11 diff
(98.4 %id)
TI_149286186   .a 3631 to 4300 781 to 86   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 696/697
(99 %)
13 diff
(98.2 %id)
D80099 brain .a 3634 to 3840 1 to 208       208/208
(100 %)
2 diff
(99.1 %id)
BM998008 lung, Metastatic Chondrosarcoma .a 3640 to 4304 683 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 665/665
(100 %)
2 diff
(99.7 %id)
CA438411 lung, Metastatic Chondrosarcoma .a 3641 to 4300 675 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 659/659
(100 %)
1 diff
(99.9 %id)
CD365664 Alveolar Macrophage, lung .a 3647 to 4304 676 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 658/658
(100 %)
5 diff
(99.3 %id)
TI_149303655   .a 3653 to 4304 786 to 117   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 670/850
(78 %)
19 diff
(97.8 %id)
BQ008561 Chondrosarcoma, Left Pubic Bone .a 3659 to 4304 660 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 642/642
(100 %)
4 diff
(99.4 %id)
CA430823 cell lines, Chondrosarcoma .a 3661 to 4304 662 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 644/644
(100 %)
0 diff
(100 %id)
BQ921593 epidermoid carcinoma, cell line, lung .a 3662 to 4298 1 to 637   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 637/637
(100 %)
0 diff
(100 %id)
TI_149309139   .a 3662 to 4304 769 to 103   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 667/988
(67 %)
14 diff
(98.6 %id)
BQ010521 Chondrosarcoma, Left Pubic Bone .a 3665 to 4304 686 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 668/668
(100 %)
13 diff
(98.1 %id)
AA055406 colon, tumor .a 3672 to 4089 449 to 1       449/449
(100 %)
14 diff
(96.9 %id)
BU680998 lung .a 3674 to 4300 669 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 653/653
(100 %)
12 diff
(98.2 %id)
DR762586 embryonic stem .a 3675 to 4100 1 to 452   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 452/452
(100 %)
9 diff
(98.1 %id)
BE045185 hepatic adenoma, Liver .a 3761 to 4303 1 to 543       543/543
(100 %)
0 diff
(100 %id)
H09993 whole brain .a 3784 to 4100 371 to 14   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 358/381
(93 %)
65 diff
(83.0 %id)
BQ018827 lung, Metastatic Chondrosarcoma .a 3784 to 4304 565 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 547/547
(100 %)
10 diff
(98.2 %id)
BU687561 lung .a 3784 to 4304 564 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 546/546
(100 %)
11 diff
(98.0 %id)
AW051619 Kidney .a 3788 to 4300 513 to 1       513/513
(100 %)
0 diff
(100 %id)
AI628980 Kidney .a 3793 to 4304 512 to 1       512/512
(100 %)
0 diff
(100 %id)
AI377184 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3794 to 4299 506 to 1       506/506
(100 %)
0 diff
(100 %id)
CN335899 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3804 to 4290 1 to 493       493/493
(100 %)
8 diff
(98.4 %id)
AA300313 thymus .a 3811 to 4084 1 to 300       300/300
(100 %)
10 diff
(96.7 %id)
BE833598 ovary .a 3811 to 4001 1 to 190       190/202
(94 %)
8 diff
(96.1 %id)
AW024849 Kidney .a 3818 to 4304 487 to 1       487/487
(100 %)
0 diff
(100 %id)
BP384956 pancreatic islet .a 3820 to 4293 1 to 500     Submitted on the opposite strand 500/500
(100 %)
9 diff
(98.2 %id)
AI351321 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3825 to 4084 286 to 1       286/286
(100 %)
10 diff
(96.6 %id)
CN344858 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3842 to 4107 26 to 285       260/285
(91 %)
6 diff
(97.9 %id)
AI276923 placenta .a 3842 to 4301 468 to 7       462/474
(97 %)
0 diff
(100 %id)
BM981625 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3842 to 4304 481 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 463/491
(94 %)
17 diff
(96.6 %id)
AW001789 Kidney .a 3843 to 4100 273 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 258/261
(98 %)
0 diff
(100 %id)
AL046835 uterus .a 3863 to 4300 1 to 438   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 438/438
(100 %)
1 diff
(99.8 %id)
AW067791 Bone, Hip .a 3865 to 4289 435 to 9       427/436
(97 %)
0 diff
(100 %id)
DB569458 hypothalamus .a 3871 to 4298 1 to 428     Submitted on the opposite strand 428/428
(100 %)
3 diff
(99.3 %id)
AI034279 senescent fibroblast .a 3889 to 4304 432 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 416/416
(100 %)
2 diff
(99.6 %id)
BM678760 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3900 to 4304 423 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 405/405
(100 %)
0 diff
(100 %id)
AI278067 placenta .a 3901 to 4301 409 to 7       403/409
(98 %)
0 diff
(100 %id)
BE886385 leiomyosarcoma, uterus .a 3902 to 4528 1 to 641       641/936
(68 %)
12 diff
(98.8 %id)
AW304845 brain, three pooled meningiomas .a 3903 to 4300 398 to 1       398/398
(100 %)
0 diff
(100 %id)
AI621302 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3909 to 4305 396 to 2       395/396
(99 %)
0 diff
(100 %id)
AW591652 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3918 to 4298 394 to 14   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 381/381
(100 %)
3 diff
(99.3 %id)
AI433273 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3919 to 4287 386 to 16       371/386
(96 %)
47 diff
(87.9 %id)
AA962448 Kidney .a 3930 to 4298 370 to 1       370/370
(100 %)
9 diff
(97.6 %id)
AA873410 Kidney .a 3945 to 4305 360 to 1       360/360
(100 %)
6 diff
(98.4 %id)
EC506838 Prostate .a 3948 to 4061 1 to 110       110/110
(100 %)
7 diff
(93.7 %id)
BQ185659 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3994 to 4452 1 to 459   tiling clone, AAA Submitted on the opposite strand 459/459
(100 %)
8 diff
(98.3 %id)
AA609233   .a 4002 to 4198 1 to 204     Submitted on the opposite strand 204/204
(100 %)
9 diff
(95.6 %id)
AW007889 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4002 to 4305 304 to 1       304/304
(100 %)
4 diff
(98.7 %id)
BQ101082 Islets of Langerhans, Pancreas .a 4010 to 4373 364 to 1   AAA Submitted on the opposite strand 364/374
(97 %)
0 diff
(100 %id)
BU628074 Bone, Enchondroma cell line .a 4012 to 4298 307 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 289/289
(100 %)
6 diff
(98.0 %id)
CA438946 lung, Lung Focal Fibrosis .a 4025 to 4304 298 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 280/298
(93 %)
0 diff
(100 %id)
AI766198 2 pooled tumors (clear cell type), Kidney .a 4031 to 4305 279 to 3       277/279
(99 %)
0 diff
(100 %id)
AI824066 2 pooled tumors (clear cell type), Kidney .a 4031 to 4305 279 to 3       277/279
(99 %)
0 diff
(100 %id)
BF437000 Prostate .a 4038 to 4301 264 to 1       264/264
(100 %)
3 diff
(98.9 %id)
AI185974 lung .a 4058 to 4304 247 to 1       247/247
(100 %)
5 diff
(98.0 %id)
AA953677 pooled .a 4066 to 4300 257 to 24   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 234/234
(100 %)
9 diff
(96.2 %id)
BF434905 Kidney .a 4066 to 4301 243 to 8       236/243
(97 %)
0 diff
(100 %id)
AA574251 breast .a 4072 to 4299 233 to 6       228/233
(97 %)
0 diff
(100 %id)
AA988359 2 pooled tumors (clear cell type), Kidney .a 4072 to 4298 238 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 227/227
(100 %)
0 diff
(100 %id)
AA932923 pooled .a 4073 to 4303 231 to 1       231/231
(100 %)
0 diff
(100 %id)
R44896 whole brain .a 4074 to 4299 235 to 9       227/235
(96 %)
0 diff
(100 %id)
F08828 brain, total brain .a 4076 to 4300 225 to 1       225/225
(100 %)
0 diff
(100 %id)
AA480381 colon .a 4076 to 4298 223 to 1       223/223
(100 %)
0 diff
(100 %id)
BE222883 brain, oligodendroglioma .a 4079 to 4299 223 to 3       221/223
(99 %)
0 diff
(100 %id)
BQ100793 Islets of Langerhans, Pancreas .a 4099 to 4375 1 to 277     Submitted on the opposite strand 277/287
(96 %)
1 diff
(99.7 %id)
CA503099 Human Lung Epithelial cells, lung .a 4107 to 4298 210 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 192/201
(95 %)
0 diff
(100 %id)
BG290985 bladder, transitional cell papilloma, cell line .a 4125 to 4298 1 to 174   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 174/174
(100 %)
2 diff
(98.9 %id)
AA902640 Kidney .a 4136 to 4301 174 to 9       166/174
(95 %)
0 diff
(100 %id)
AA489733 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4143 to 4484 1 to 340   fully sequenced,   340/340
(100 %)
3 diff
(99.2 %id)
BQ187950 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4161 to 4704 543 to 1     Submitted on the opposite strand 543/543
(100 %)
3 diff
(99.5 %id)
GD140195   .a 4194 to 4301 7 to 114       108/129
(83 %)
1 diff
(99.3 %id)
EC570725 Prostate .a 4215 to 4303 91 to 3       89/108
(82 %)
0 diff
(100 %id)
TI_151770232   .a 4232 to 4836 108 to 713       606/1228
(49 %)
14 diff
(98.9 %id)
TI_151802989   .a 4232 to 4831 76 to 674   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 599/599
(100 %)
29 diff
(95.2 %id)
BU733496 eye, optic nerve .a 4296 to 4821 554 to 29   AAA   526/536
(98 %)
0 diff
(100 %id)
AI568634 anaplastic oligodendroglioma, brain .a 4312 to 4809 498 to 1       498/498
(100 %)
2 diff
(99.6 %id)
AI128222 uterus .a 4335 to 4831 497 to 1   tiling clone,   497/497
(100 %)
0 diff
(100 %id)
AI497925 anaplastic oligodendroglioma, brain .a 4362 to 4809 448 to 1       448/448
(100 %)
2 diff
(99.6 %id)
AI093437 uterus .a 4405 to 4831 427 to 1       427/427
(100 %)
1 diff
(99.8 %id)
AA489630 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4454 to 4831 375 to 1   fully sequenced,   375/375
(100 %)
5 diff
(98.7 %id)
AI863721 2 pooled tumors (clear cell type), Kidney .a 4489 to 4833 350 to 6   tiling clone,   345/350
(98 %)
0 diff
(100 %id)
AA602295 normal prostate, Prostate .a 4578 to 4831 274 to 23   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 252/252
(100 %)
5 diff
(98.1 %id)
AA602305 normal prostate, Prostate .a 4578 to 4831 274 to 23   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 252/252
(100 %)
3 diff
(98.9 %id)
AW863801 stomach_normal .a 4601 to 4782 1 to 184       184/184
(100 %)
10 diff
(94.6 %id)
DC428435   .b 1 to 591 1 to 591   tiling clone,   591/591
(100 %)
1 diff
(99.9 %id)
BQ892572 epidermoid carcinoma, cell line, lung .b 21 to 763 1 to 749       749/829
(90 %)
7 diff
(99.2 %id)
AK293644 cerebellum .b 57 to 1708 1 to 1652   tiling clone,   1652/1652
(100 %)
0 diff
(100 %id)
DC305078 cerebellum .b 57 to 605 1 to 549       549/549
(100 %)
0 diff
(100 %id)
AW499645 lymph .b 141 to 544 8 to 411       404/411
(98 %)
6 diff
(98.6 %id)
CF143120 lymph .b 141 to 597 8 to 464       457/464
(98 %)
8 diff
(98.3 %id)
CF143192 lymph .b 141 to 705 8 to 572       565/572
(98 %)
6 diff
(99.0 %id)
TI_154174450   .b 141 to 646 87 to 597       511/673
(75 %)
18 diff
(97.4 %id)
TI_154174499   .b 141 to 792 82 to 733       652/658
(99 %)
10 diff
(98.5 %id)
TI_158439381   .b 141 to 758 80 to 699       620/710
(87 %)
16 diff
(97.8 %id)
CO248631 Chondrosarcoma Lung Metastasis cell lines, lung .b 303 to 992 1 to 690       690/849
(81 %)
8 diff
(99.1 %id)
AL583235 B cells from Burkitt lymphoma .c 1 to 968 1 to 953   tiling clone,   953/953
(100 %)
42 diff
(95.6 %id)
AL537412 brain, fetal brain .c 292 to 1071 1 to 778   tiling clone,   778/806
(96 %)
5 diff
(99.4 %id)
AL583446 B cells from Burkitt lymphoma .c 1071 to 2331 838 to 1       666/838
(79 %)
32 diff
(96.2 %id)
CF143567 lymph .c 1367 to 1736 8 to 377       370/377
(98 %)
6 diff
(98.5 %id)
TI_154175004   .c 1367 to 1755 80 to 468   tiling clone,   389/390
(99 %)
0 diff
(100 %id)
BX364164   .c 1411 to 1755 346 to 1       346/484
(71 %)
4 diff
(99.2 %id)
AL566795 brain, fetal brain .c 1490 to 2361 871 to 1   tiling clone,   871/871
(100 %)
8 diff
(99.1 %id)
BM726650 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1558 to 2090 1 to 533     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 533/533
(100 %)
2 diff
(99.7 %id)
BF182899 large cell carcinoma, lung .c 1803 to 2520 1 to 703       703/717
(98 %)
16 diff
(97.8 %id)
BG437631 large cell carcinoma, lung .c 1803 to 2490 1 to 687   tiling clone,   687/687
(100 %)
4 diff
(99.5 %id)
BQ943761 large cell carcinoma, lung .c 1804 to 2729 27 to 955       929/970
(95 %)
29 diff
(97.1 %id)
BM472991 duodenal adenocarcinoma, cell line, small intestine .c 1807 to 2377 1 to 574       574/1093
(52 %)
30 diff
(97.3 %id)
BF333034 breast .c 1856 to 2418 586 to 23       564/586
(96 %)
0 diff
(100 %id)
BM310689 Pancreas, Purified pancreatic islet .c 1897 to 2406 11 to 520       510/520
(98 %)
6 diff
(98.9 %id)
BF337252 brain, glioblastoma with EGFR amplification .c 1933 to 2598 1 to 661       661/661
(100 %)
7 diff
(99.0 %id)
AI640301 Kidney .c 1939 to 2379 441 to 1       441/441
(100 %)
2 diff
(99.6 %id)
BF357122 head_neck .c 1990 to 2424 43 to 475       433/487
(88 %)
10 diff
(98.0 %id)
BE181457 head_neck .c 1998 to 2251 256 to 2     Submitted on the opposite strand 255/265
(96 %)
0 diff
(100 %id)
BE799799 lung, small cell carcinoma .c 2272 to 2871 39 to 638   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 600/638
(94 %)
6 diff
(99.1 %id)
FN157183 breast carcinoma .c 2290 to 2394 108 to 1     Submitted on the opposite strand 108/108
(100 %)
3 diff
(97.3 %id)
BM681294 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 2336 to 2903 586 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 568/568
(100 %)
0 diff
(100 %id)
AI431885 Kidney .c 2366 to 2871 506 to 1       506/506
(100 %)
1 diff
(99.9 %id)
AW444991   .c 2414 to 2896 503 to 18   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 486/486
(100 %)
3 diff
(99.4 %id)
AI433450 Kidney .c 2427 to 2871 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AW001653 Kidney .c 2492 to 2903 412 to 1       412/412
(100 %)
1 diff
(99.8 %id)
AI079339 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2498 to 2903 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AI264640 Kidney .c 2508 to 2903 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AI369314 anaplastic oligodendroglioma, brain .c 2508 to 2908 406 to 3       404/406
(99 %)
0 diff
(100 %id)
AW469744 pooled .c 2538 to 2875 338 to 1       338/338
(100 %)
0 diff
(100 %id)
AI768892 Kidney .c 2575 to 2903 330 to 1       330/330
(100 %)
1 diff
(99.7 %id)
BF197481 Kidney .c 2575 to 2903 329 to 1       329/329
(100 %)
0 diff
(100 %id)
AI985010 Kidney .c 2577 to 2871 295 to 1       295/298
(98 %)
2 diff
(99.4 %id)
AW450376   .c 2579 to 2903 343 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 326/366
(89 %)
4 diff
(99.0 %id)
AA732087 germinal center B cell .c 2609 to 2912 304 to 1       304/304
(100 %)
0 diff
(100 %id)
AA894733 Kidney .c 2616 to 2904 289 to 1       289/289
(100 %)
1 diff
(99.7 %id)
BM714112 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 2638 to 2871 11 to 244   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 234/244
(95 %)
6 diff
(97.6 %id)
BM727248 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 2638 to 2871 11 to 244   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 234/244
(95 %)
6 diff
(97.6 %id)
FN101293 breast carcinoma .c 2643 to 2748 1 to 107       107/110
(97 %)
2 diff
(98.2 %id)
BM675293 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 2679 to 2887 209 to 1   fully sequenced, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 209/209
(100 %)
0 diff
(100 %id)
BU740801 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 2679 to 2887 209 to 1   fully sequenced, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 209/209
(100 %)
0 diff
(100 %id)
CF994185 Human Placenta, placenta .c 2776 to 3463 29 to 714   tiling clone,   686/715
(95 %)
16 diff
(97.8 %id)
BF935732 nervous_tumor .c 3262 to 3505 15 to 255   tiling clone,   241/263
(91 %)
4 diff
(98.5 %id)
AI804191 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 3364 to 3670 307 to 1       307/307
(100 %)
6 diff
(98.1 %id)
BG107650 Bone, osteosarcoma, cell line .c 3437 to 4104 1 to 676   tiling clone,   676/1065
(63 %)
28 diff
(97.4 %id)
BG476728 melanotic melanoma, skin .c 3468 to 4099 1 to 640       640/894
(71 %)
34 diff
(96.2 %id)
BE410485 choriocarcinoma, placenta .c 3478 to 4160 11 to 693   tiling clone,   683/734
(93 %)
10 diff
(98.7 %id)
BE543043 cervical carcinoma cell line, cervix .c 3526 to 4303 1 to 779   tiling clone,   779/883
(88 %)
23 diff
(97.4 %id)
AI738843 ovary, tumor, 5 pooled (see description) .c 3749 to 4144 400 to 1   tiling clone,   400/400
(100 %)
9 diff
(97.8 %id)
DC402276 testis .d 1 to 353 1 to 353   tiling clone,   353/353
(100 %)
0 diff
(100 %id)
AK303061 testis .d 9 to 1618 1 to 1610 exact tiling clone,   1610/1610
(100 %)
6 diff
(99.7 %id)
DC404532 testis .d 9 to 490 1 to 482       482/482
(100 %)
5 diff
(99.0 %id)
NM_001142272.1   .d 13 to 3217 1 to 3205 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3205/3205
(100 %)
0 diff
(100 %id)
DC395000 testis .d 13 to 514 1 to 502       502/502
(100 %)
0 diff
(100 %id)
DC404361 testis .d 13 to 615 1 to 605       605/605
(100 %)
2 diff
(99.7 %id)
BP276076 Kidney .d 87 to 656 1 to 570       570/580
(98 %)
1 diff
(99.9 %id)
DC361425 Kidney .d 89 to 659 1 to 571       571/571
(100 %)
0 diff
(100 %id)
CD244302 testis .e 1 to 804 1 to 809   tiling clone,   809/827
(97 %)
14 diff
(98.4 %id)
BM908945 astrocytoma grade IV, cell line, brain .e 753 to 1189 465 to 905   tiling clone,   441/1062
(41 %)
22 diff
(98.0 %id)
BM560676 astrocytoma grade IV, cell line, brain .e 753 to 1308 453 to 1009   tiling clone,   557/1039
(53 %)
31 diff
(97.1 %id)
BM560725 astrocytoma grade IV, cell line, brain .e 753 to 1321 453 to 1025   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 573/1026
(55 %)
34 diff
(96.7 %id)
BF204879 muscle, rhabdomyosarcoma .f 1 to 732 1 to 726 V89C S91L E92S C93A L94W ...     726/832
(87 %)
11 diff
(98.7 %id)
BG828844 muscle, rhabdomyosarcoma .f 1 to 793 1 to 796 F178L E179S Y181T C182V S183A ... tiling clone,   796/796
(100 %)
10 diff
(98.8 %id)
BI114496 muscle, rhabdomyosarcoma .f 1 to 768 1 to 781 D175E E176*     779/1016
(76 %)
29 diff
(97.2 %id)
AW243089 Kidney .f 131 to 808 690 to 14   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 677/677
(100 %)
8 diff
(98.9 %id)
AI651540 Kidney .f 254 to 811 562 to 5   tiling clone,   558/562
(99 %)
2 diff
(99.7 %id)
CA430713 cell lines, Chondrosarcoma .f 362 to 810 467 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 449/449
(100 %)
0 diff
(100 %id)
AL120678 melanoma (MeWo cell line) .f 389 to 810 1 to 422   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 422/422
(100 %)
0 diff
(100 %id)
AW272095 Kidney .f 499 to 809 326 to 16       311/326
(95 %)
0 diff
(100 %id)
CN335900 embryonic stem cells, cell lines H1, H7, andH9 .g 1 to 669 1 to 668 exact tiling clone,   668/668
(100 %)
1 diff
(99.9 %id)
BX491896   .h-u 1 to 188 11 to 220   tiling clone,   210/220
(95 %)
6 diff
(97.3 %id)
DA145199 amygdala .h-u 54 to 632 2 to 580   tiling clone, capped   579/579
(100 %)
6 diff
(99.0 %id)
BX478582   .h-u 156 to 725 1 to 570   tiling clone,   570/570
(100 %)
8 diff
(98.6 %id)
BX645935   .h-u 158 to 850 1 to 693   tiling clone,   693/693
(100 %)
4 diff
(99.5 %id)
CN271537 embryonic stem cells, DMSO-treated H9 cellline .h-u 210 to 595 1 to 386       386/386
(100 %)
3 diff
(99.3 %id)
AK094817 brain .h-u 399 to 3185 1 to 2785 exact tiling clone, available from FLJ,   2785/2785
(100 %)
9 diff
(99.7 %id)
DA208550 brain .h-u 400 to 976 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
AW847069 colon .h-u 1288 to 1529 242 to 2       241/242
(99 %)
0 diff
(100 %id)
DA684485   .h-u 1345 to 1890 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BI006253 kidney_tumor .h-u 1437 to 1683 1 to 247       247/247
(100 %)
1 diff
(99.6 %id)
BI006987 kidney_tumor .h-u 1437 to 1728 1 to 292       292/292
(100 %)
0 diff
(100 %id)
BF935759 nervous_tumor .h-u 1448 to 1881 439 to 2     Submitted on the opposite strand 438/442
(99 %)
0 diff
(100 %id)
BX509467   .h-u 1781 to 2394 1 to 614       614/614
(100 %)
0 diff
(100 %id)
DA892002 rectum .h-u 2033 to 2597 2 to 566   tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
BI116619 lung, small cell carcinoma .h-u 2053 to 2947 1 to 901       901/902
(99 %)
44 diff
(95.2 %id)
DB322858   .h-u 2587 to 3185 599 to 1       599/599
(100 %)
2 diff
(99.7 %id)
DA957444 Spleen .i 1 to 549 2 to 550 M75V R155K tiling clone, capped   549/549
(100 %)
2 diff
(99.7 %id)
DB498369 hypothalamus .j 1 to 514 1 to 514 A143X tiling clone,   514/514
(100 %)
2 diff
(99.7 %id)
AW772114 Kidney .k 1 to 553 557 to 5 N2X L66X tiling clone,   553/557
(99 %)
0 diff
(100 %id)
AW611882 Kidney .k 10 to 554 553 to 11   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 543/543
(100 %)
9 diff
(98.4 %id)
AI253065 Kidney .k 151 to 549 410 to 12   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 399/399
(100 %)
0 diff
(100 %id)
BF510355   .k 151 to 554 419 to 16   tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 404/404
(100 %)
0 diff
(100 %id)
AW450732   .k 174 to 554 396 to 16   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 381/381
(100 %)
1 diff
(99.8 %id)
AI521779 Kidney .k 187 to 552 366 to 1       366/366
(100 %)
1 diff
(99.8 %id)
DA340180 hippocampus .l 1 to 584 2 to 586 D11G S12Q A13R Y14V M15H ... tiling clone, capped   585/585
(100 %)
1 diff
(99.9 %id)
BC009036 Brain, anaplastic oligodendroglioma with1p/19q loss .m-u 1 to 896 21 to 916 S2P R4P E5G T6D R7P ... tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 896/916
(97 %)
6 diff
(99.4 %id)
BI009385 kidney_tumor .n-u 1 to 465 5 to 468 P19A S25R S29R L36V V38G ... tiling clone,   468/469
(99 %)
22 diff
(95.4 %id)
BG980427 colon_normal .o 1 to 322 8 to 327 A13H T14C A15T H16P P17C ... tiling clone,   320/329
(97 %)
6 diff
(98.2 %id)
DA504498 brain .p 1 to 517 2 to 518   tiling clone, capped   517/517
(100 %)
3 diff
(99.5 %id)
DB316027 brain .p 1870 to 2404 535 to 1   tiling clone,   535/535
(100 %)
1 diff
(99.9 %id)
AW362014 colon .q-u 1 to 501 503 to 3 S2N H3P I5N Q6S P7A ... tiling clone,   501/503
(99 %)
0 diff
(100 %id)
AF038180 brain Gene RAB11FIP3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BG982076 colon_normal Gene RAB11FIP3, variant not shown         This clone was ignored    
DA184170 amygdala Gene RAB11FIP3, variant not shown       capped      
BX105839 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene RAB11FIP3, variant not shown         This clone was ignored    
CN285643 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene RAB11FIP3, variant not shown              
BX406593 fetal liver, Liver Gene RAB11FIP3, variant not shown         This clone was ignored    
BX406594 fetal liver, Liver Gene RAB11FIP3, variant not shown         This clone was ignored    
AL697654 human skeletal muscle Gene RAB11FIP3, variant not shown              
DB315566 brain Gene RAB11FIP3, variant not shown              
DA494609 brain Gene RAB11FIP3, variant not shown       capped      
AI678591 poorly differentiated adenocarcinoma withsignet ring cell features, stomach Gene RAB11FIP3, variant not shown              
BG033300 breast, mammary adenocarcinoma, cell line Gene RAB11FIP3, variant not shown              
BQ684196 melanotic melanoma, cell line, skin Gene RAB11FIP3, variant not shown         Suspected internal deletion, this clone was ignored    
DB320812 Kidney Gene RAB11FIP3, variant not shown         This clone was ignored    
DA630129 Kidney Gene RAB11FIP3, variant not shown       capped This clone was ignored    
DB371523 ovary, tumor tissue Gene RAB11FIP3, variant not shown              
DA812201 ovary, tumor tissue Gene RAB11FIP3, variant not shown       capped      
TI_1948226615   Gene RAB11FIP3, variant not shown         Suspected internal deletion, this clone was ignored    
BM681131 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene RAB11FIP3, variant not shown         This clone was ignored    
BM727704 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene RAB11FIP3, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j, .k, .l, .m-u, .n-u, .o, .p, .q-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI